Universal Technical Institute (UTI) EVP earns 38,878 performance-based shares

Rhea-AI Filing Summary

Universal Technical Institute, Inc. reported that its EVP and Chief Legal Officer, Christopher Kevane, acquired 38,878 shares of common stock on 12/08/2025 at a price of $0.00 per share. These shares were earned under a performance-based restricted stock unit award tied to the company’s achievement of specified performance criteria.

Following this transaction, Kevane directly beneficially owns 112,555 shares of Universal Technical Institute common stock. The filing indicates this was a routine equity compensation event rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kevane Christopher E.

Role EVP and Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	38,878	$0.00	--

Holdings After Transaction: Common Stock, $0.0001 par value — 112,555 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kevane Christopher E.

(Last) (First) (Middle)

4225 E. WINDROSE DRIVE, SUITE 200

(Street)

PHOENIX AZ 85032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL TECHNICAL INSTITUTE INC [ UTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	12/08/2025		A		38,878(1)	A	$0.00	112,555	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares underlying a performance-based restricted stock unit award that was earned on the basis of the issuer's achievement of certain performance vesting criteria (as stated in the agreement governing the award).

	/s/ Christopher Kevane	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UTI report in this Form 4?

UTI reported that EVP and Chief Legal Officer Christopher Kevane acquired 38,878 shares of common stock on 12/08/2025 through a performance-based restricted stock unit award.

At what price were the new UTI shares acquired by the executive?

The 38,878 Universal Technical Institute shares were acquired at a price of $0.00 per share as part of equity compensation, not an open-market purchase.

How many UTI shares does the reporting person own after this transaction?

After the transaction, Christopher Kevane beneficially owns 112,555 shares of Universal Technical Institute common stock, held directly.

What is the role of the reporting person at Universal Technical Institute (UTI)?

The reporting person, Christopher Kevane, serves as EVP and Chief Legal Officer of Universal Technical Institute, Inc.

What type of award resulted in the 38,878 UTI shares being issued?

The 38,878 shares represent stock underlying a performance-based restricted stock unit award that was earned based on achievement of specified performance vesting criteria.

Is this UTI Form 4 transaction a purchase on the open market?

No. The transaction reflects the earning and issuance of shares from a performance-based restricted stock unit award at $0.00 per share, not an open-market purchase.